FDA Lifts Compounding Restrictions on Weight-Loss Drugs
The FDA has lifted its restrictions on compounding GLP-1 weight-loss drugs, but with some conditions. The agency allows compounding in cases of “clinical need,” such as when a patient is allergic to a certain dye or can’t take the drug in its current form. However, this decision does not apply to making or selling unauthorized … Read more